openPR Logo
Press release

COVID-19 Impact on Clinical Trial Supplies Market 2020 | Analysis By Catalent, Thermo Fisher Scientific, Almac Group, Parexel International Corporation, Biocair, UDG Healthcare plc (Sharp), PCI Healthcare Services, Owens & Minor, KLIFO, Rubicon Research P

05-25-2020 05:36 PM CET | Health & Medicine

Press release from: The Insight Partners

/ PR Agency: The Insight Partners
Clinical Trial Supplies Market

Clinical Trial Supplies Market

The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries including Life science Industry, and many more. Trade barriers are further restraining the demand- supply outlook. As government of different regions have already announced total lockdown and temporarily shutdown of industries, the overall production process being adversely affected; thus, hinder the overall Clinical Trial Supplies market globally. This report on 'Clinical Trial Supplies market' provides the analysis on impact on Covid-19 on various business segments and country markets. The report also showcase market trends and forecast to 2027, factoring the impact of Covid -19 Situation.

Get the inside scope of the Sample report @ https://www.theinsightpartners.com/sample/TIPRE00009672/?openpr-10225

The clinical trial supplies market was valued at US$ 1,867.44 million in 2019 and is expected to grow at a CAGR of 7.4% from 2020 to 2027 to reach US$ 3,298.91 million by 2027.

Company Profiles

Catalent, Inc.
Thermo Fisher Scientific, Inc.
Almac Group
Parexel International Corporation
Biocair
UDG Healthcare plc (Sharp)
PCI Healthcare Services
Owens & Minor Inc.
KLIFO
Rubicon Research Pvt. Ltd.

Market Insights

Increasing Pharmaceutical and Biopharmaceutical R&D Expenditures

Research and development (R&D) is a significant and essential part of the business of pharmaceuticals and biopharmaceuticals companies. R&D enables them to come up with new molecules for various therapeutic applications with substantial medical and commercial potential. R&D spending by biopharmaceutical companies has also increased over the years. As per the report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expense of these companies has increased from US$ 59.6 billion in 2015 to US$ 79.6 billion in 2018. R&D expenditures are done for discovering, examining, and producing new products, upfront payments, and milestones, improving existing outcomes, as well as demonstrating product efficacy and regulatory compliance before launch. The R&D investments differ as per their need and demand for the supplies for a clinical trial. The cost includes materials, supplies used, and salaries, also the cost of developing quality control. Drug improvement and discovery is a time-consuming and expensive process. The process stages range from early detection or design to development and regulatory approval, and the entire process can take more than 10-15 years. Throughout the drug growing phase, various testing services are required to check the quality and efficacy of the drug substance. Several manufacturers are investing in clinical supplies in the pharmaceutical industry. For instance, in February 2019, Sharp spent US$ 650,000 in the interactive response technology (IRT) solution to enable appropriate supply allocation to decrease the costs incurred by the overproduction for sponsors. Therefore, the pharmaceutical and biotech companies are dependent on the supplies for the services to the clinical trials, which is expected to drive the growth of the market.

Challenges for Clinical Trials Due to Negative Impact of Corona Virus

The rise in the number of positive corona cases has impacted negatively on the clinical trial supplies market. The pandemic situation across the world has triggered an evolution in the global healthcare sector with the rising demand for solutions to tackle the coronavirus infection. Therefore, the companies are likely to increase their clinical trial activities, with the introduction of new ones, to find out the solutions against the COVID-19 (coronavirus).

Moreover, the highly contagious nature of the COVID-19 has halted the recruitments in the clinical trials industry. Safety is essential for on-sight professionals, and various organizations are providing guidelines for the protection of people during clinical trials. Furthermore, the mandatory isolations, lockdowns, and work from home or shutdown conditions have disrupted the workflow of clinical trials. Thus, the emergence of this pandemic is expected to slow down market growth in the coming days.

TOC of Market Report Contains:

Industry Overview
Production Market Analysis
Sales Market Analysis
Consumption Market Analysis
Production, Sales and Consumption Market Comparison Analysis
Major Manufacturers Production and Sales Market Comparison Analysis
Major Type of Analysis
Major Organization Size Analysis
Industry Chain Analysis
Global and Regional Market Forecast
Major Manufacturers Analysis
New Project Investment Feasibility Analysis
And More...

Global Clinical Trial Supplies Market - By Product & Service

Logistics & Distribution
Manufacturing
Packaging & Labelling

Global Clinical Trial Supplies Market - By Stage

Phase III
Phase II
Bioequivalence Studies
Phase I

Global Clinical Trial Supplies Market - By Drug Type

Small-molecule Drugs
Biologic Drugs

Global Clinical Trial Supplies Market - By

Application
Oncology
Cardiovascular Diseases
Neurological Disorders
Respiratory Disorders
Others

Clinical Trial Supplies Market - By Geography

North America
Europe
Asia Pacific
Middle East & Africa
South America

Reasons To Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Click to buy full report with all description: https://www.theinsightpartners.com/buy/TIPRE00009672/?openpr-10225

Contact Us:
The Insight Partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release COVID-19 Impact on Clinical Trial Supplies Market 2020 | Analysis By Catalent, Thermo Fisher Scientific, Almac Group, Parexel International Corporation, Biocair, UDG Healthcare plc (Sharp), PCI Healthcare Services, Owens & Minor, KLIFO, Rubicon Research P here

News-ID: 2056973 • Views:

More Releases from The Insight Partners

A Complete Study Guide to RF Transceivers
A Complete Study Guide to RF Transceivers
The RF transceivers industry is primarily driven by the increasing demand for wireless communication technologies. With the rise of mobile devices, IoT applications, and smart home technologies, there is a significant need for efficient and reliable RF transceivers that can facilitate seamless communication over various frequency bands. As consumers and businesses alike seek more robust connectivity solutions, the demand for RF transceivers continues to grow, prompting manufacturers to innovate and
A Complete PDF Guide to Geotechnical Instrumentation and Monitoring
A Complete PDF Guide to Geotechnical Instrumentation and Monitoring
The Geotechnical Instrumentation and Monitoring Industry is expected to register a CAGR of 10.3% from 2025 to 2031. The rapid growth in infrastructure development, including roads, bridges, tunnels, and buildings, is a major driver for the geotechnical instrumentation and monitoring industry. As these projects become more complex and large-scale, there is a greater need for precise monitoring of soil, rock, and structural conditions. Geotechnical instruments help assess the stability and
Top Leading Companies Driving Growth in Thermal Management
Top Leading Companies Driving Growth in Thermal Management
The thermal management sector is progressively using novel materials such as graphene, carbon nanotubes, and sophisticated phase-change materials (PCMs). These materials have greater heat dissipation properties compared to standard materials, allowing for more efficient cooling systems that are lighter, more compact, and energy-efficient. Nanotechnology also enables the production of materials with increased thermal conductivity, which improves heat management efficiency across a wide range of applications. Get a PDF Copy: https://www.theinsightpartners.com/sample/TIPTE100001349/?utm_source=OpenPR&utm_medium=10183 The Innovative
A Complete Study Guide to Nuclear Power Generation
A Complete Study Guide to Nuclear Power Generation
The nuclear power generation industry trends are likely to provide novel solutions to meet the skyrocketing demand for electricity. Rising energy demand and growing focus on energy transition to clean alternatives are expected to propel the need for nuclear power plants during the forecast period. Energy demand worldwide is increasing due to population outbursts and increasing industrialization. Various countries are seeking diverse and reliable energy sources to decrease their dependence

All 5 Releases


More Releases for Clinical

Miami Clinical Research Sets the Standard for Clinical Trials
Miami Clinical Research, a frontrunner in the world of clinical trials and medical research, has emerged as the prime choice for global corporate pharmaceutical giants. With a deep understanding of the complexities of medical studies, the organization champions the crucial role of research in the evolution of transformative therapeutic interventions. Miami, FL - Renowned as a first-rate center for professional medical exploration, Miami Clinical Research [https://miamiclinicalresearch.com] boasts state-of-the-art facilities, advanced technologies,
E-Clinical Solutions Market: Revolutionizing Healthcare and Clinical Trials
Introduction The e-Clinical solutions market has become a pivotal component of the healthcare and pharmaceutical industries. E-Clinical solutions refer to a set of software, tools, and platforms designed to streamline clinical trials and healthcare management. These solutions include electronic data capture (EDC), clinical trial management systems (CTMS), laboratory information management systems (LIMS), and other integrated tools that improve the efficiency, accuracy, and speed of clinical trials and healthcare services. The primary
E-Clinical Solutions Market: Revolutionizing Clinical Trials
The e-clinical solutions market has experienced significant growth in recent years, driven by the increasing complexity of clinical trials and the need for efficient, accurate, and compliant data management. E-clinical solutions provide a comprehensive suite of tools and technologies to streamline clinical trial processes, accelerate drug development, and improve patient outcomes. Market Size and Growth The global e-clinical solutions market is estimated to be worth billions of dollars, with a significant portion
Clinical Trials Management System Market Optimizing Clinical Trials: The Crucial …
Clinical Trials Management System Market to reach over USD 5.06 billion by the year 2031- Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical